ArticleEuropean journal of medical research2025
Dietary vitamin E intake and all-cause mortality in patients with osteoarthritis: a prospective cohort study using NHANES data.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe potential influence of dietary vitamin E in osteoarthritis (OA) progression has been explored; however, its association with mortality risk in patients with OA remains unclear. This study aimed to investigate the relationship between dietary vitamin E intake and all-cause mortality among US adults with OA.
methodsThis cross-sectional analysis included 2,974 adults with OA from the National Health and Nutrition Examination Survey cycles spanning 2003-2018. Mortality data were obtained by linking to the National Death Index, with follow-up until December 31, 2019. Cox proportional hazards models were used to evaluate the association between dietary vitamin E intake and all-cause mortality in patients with OA. Restricted cubic spline analyses investigated potential nonlinear dose-response relationships. Stratified analyses further explored mortality risk variations across subgroups to identify high-risk populations.
resultsAfter comprehensive multivariable adjustment, a higher dietary vitamin E intake was significantly inversely associated with all-cause mortality in patients with OA (P for trend < 0.001). Compared with the lowest quartile (Q1) of intake, the adjusted hazard ratios (HRs) for mortality in Q2, Q3, and Q4 were 0.86 [95% confidence interval (CI) 0.74-1.00], 0.76 (95% CI 0.64-0.90), and 0.61 (95% CI 0.50-0.74), respectively. Restricted cubic spline analysis revealed a nonlinear relationship (P for nonlinearity = 0.025), with a threshold effect observed at 8.554 mg/day vitamin E consumption. Below 8.55 mg/day, each 1-mg increment in vitamin E intake reduced the mortality risk by 7.6% (HR: 0.92, 95% CI 0.89-0.96; P < 0.001) without significant correlation above this threshold (HR: 0.98, 95% CI 0.95-1.01; P = 0.23).
conclusionsThis national cohort study revealed a nonlinear inverse association between dietary vitamin E intake and mortality in patients with OA, with a threshold of 8.55 mg/day. Sub-threshold intake demonstrated a significant reduction in mortality, potentially informing OA nutritional management. Therefore, prospective studies are required to establish causality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.